StockData
Akari Therapeutics Plc logo

Akari Therapeutics Plc (AKTX) KPIs and segments

AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 0/30
$5.70−0.81 (-12.44%)

Close on Nov 17, 2026Market cap $11.10MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Akari Therapeutics's business

Coming soon

This tab will track the numbers specific to Akari Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?